Resolve, Directing the Department of Health and Human Services To Amend Its Rules Governing the Use of Certain Antipsychotic Drugs by Children Enrolled in MaineCare

Sec. 1. Rules. Resolved: That the Department of Health and Human Services shall amend its rules pertaining to the use of atypical antipsychotic medications by a child under 17 years of age enrolled in MaineCare to require that the prescriber of atypical antipsychotic medication beyond the recommended period provide documented justification as to why the child should continue taking the medication and to require that the prescriber perform a timely assessment and ongoing monitoring of metabolic and neurologic variables of the child in accordance with the American Academy of Child and Adolescent Psychiatry's Practice Parameter for the Use of Atypical Antipsychotic Medications in Children and Adolescents.

summary

This resolve directs the Department of Health and Human Services to amend its rules governing the use of atypical antipsychotic drugs by children enrolled in MaineCare to require that the prescriber of a drug beyond the recommended period provide documented justification and perform a timely assessment and ongoing monitoring of metabolic and neurologic variables in accordance with the American Academy of Child and Adolescent Psychiatry's Practice Parameter for the Use of Atypical Antipsychotic Medications in Children and Adolescents.